РЕКОНСТРУКТИВНО-ПЛАСТИЧЕСКИЕ ОПЕРАЦИИ У БОЛЬНЫХ С BRCA1-АССОЦИИРОВАННЫМ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ

РЕКОНСТРУКТИВНО-ПЛАСТИЧЕСКИЕ ОПЕРАЦИИ У БОЛЬНЫХ С BRCA1-АССОЦИИРОВАННЫМ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ

Bibliographic Details
Format:	Article
Language:	Russian
Published:	Pavlov First Saint Petersburg State Medical University 2018-01-01
Series:	Вестник хирургии имени И.И. Грекова
Subjects:	рак молочной железы реконструктивно-пластическая операция
Online Access:	https://www.vestnik-grekova.ru/jour/article/view/536

Similar Items

THE SINGLE-STAGE AND DELAYED RECONSTRUCTIVE PLASTY IN BREAST CANCER PATIENTS
by: Ye. M. Bit-Sava, et al.
Published: (2018-01-01)

ИНТРАОПЕРАЦИОННАЯ ФОТОДИНАМИЧЕСКАЯ ТЕРАПИЯ БОЛЬНОЙ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ IIIC (8-ЛЕТНИЙ ПЕРИОД БЕЗРЕЦИДИВНОГО НАБЛЮДЕНИЯ)
Published: (2017-01-01)

Vliyanie rekonstruktivno-plasticheskikh operatsiy na kachestvo zhizni bol'nykh rakom molochnoy zhelezy v otdalennom periode
by: Kh S Arslanov, et al.
Published: (2006-12-01)

RADICAL BREAST RESECTION WITH SKIN-MUSCULAR LATISSIMUS DORSI FLAP GRAFTING
by: E. M. Bit-Sava, et al.
Published: (2018-01-01)

Метод СВЧ-радиотермометрии в комплексной диагностике рака молочной железы
Published: (2019-09-01)

Влияние реконструктивно-пластических операций на качество жизни больных раком молочной железы
by: Юрий Алексеевич Винник, et al.
Published: (2016-03-01)

Клинико-экономическая оценка доцетаксела тригидратат (Таксотер) при адъювантной и химиотерапии первой линии рака молочной железы
Published: (2018-07-01)

INTRAOPERATIVE PHOTODYNAMIC THERAPY IN PATIENT WITH STAGE IIIC BREAST CANCER (8 YEARS WITHOUT RECURRENCE)
by: A. D. Kaprin, et al.
Published: (2017-01-01)

Сравнительный фармакоэкономический анализ применения анастрозола, летрозола и экземестана при адъювантной терапии рака молочной железы
Published: (2018-06-01)

СОВРЕМЕННЫЙ ПОДХОД К ПРОБЛЕМЕ ДИАГНОСТИКИ И ЛЕЧЕНИЯ БОЛЬНЫХ РАКОМ ЩИТОВИДНОЙ ЖЕЛЕЗЫ
Published: (2018-01-01)

Оценка качества жизни больных раком предстательной железы после радикальной простатэктомии
by: F. A. Guliev, et al.
Published: (2017-09-01)

Occurrence of BRCA1 and BRCA2 mutation in pancreatic cancer patients
by: A. A. Kashintsev, et al.
Published: (2016-02-01)

Tayverb/Tyverb (lapatinib) – pervyy dvoynoy anti-ErbB1(EGFR)i anti-ErbB2(HER2)-ingibitor v lechenii mestno-rasprostranennogo i metastaticheskogo raka molochnoy zhelezy zaregistrirovan v Rossiyskoy Federatsii
by: - -
Published: (2008-03-01)

Problemy endokrinoterapii raka molochnoy zhelezy u muzhchin
by: E I Borisova, et al.
Published: (2009-03-01)

A new aproach to the treatment of cervix uteri patholog
by: S V Murakov, et al.
Published: (2012-12-01)

Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
by: V F Semiglazov, et al.
Published: (2009-09-01)

Influence of ecological factors on dynamics of parameters of the hormonal status at an estimation of ways of deenergizing of function of ovaries at the patients, suffering a cancer of a mammary gland
by: S K Dzhubalieva, et al.
Published: (2009-06-01)

Some clinical morphological and molecular genetic aspects in patients with clinical signs of hereditary breast cancer
by: Yu S Shatova, et al.
Published: (2018-04-01)

ВЫЖИВАЕМОСТЬ БОЛЬНЫХ БИЛАТЕРАЛЬНЫМ ПОЧЕЧНО-КЛЕТОЧНЫМ РАКОМ ПОСЛЕ НЕФРОНСОХРАНЯЮЩЕЙ ОПЕРАЦИИ. ОБЗОР ЛИТЕРАТУРЫ
Published: (2021-06-01)

Fulvestrant v sovremennoy terapii rasprostranennogo raka molochnoy zhelezy: farmakoekonomicheskoe obosnovanie
by: V P Komarova, et al.
Published: (2007-09-01)

Kachestvo zhizni i simptomyu bol'nykh disseminirovannym gormonopozitivnym rakom molochnoy zhelezy v postmenopauze na fone primeneniya Fazlodeksa
by: A A Novik, et al.
Published: (2009-06-01)

Regional'naya programma lecheniya bol'nykh pervichno-generalizovannym i metastaticheskim rakom molochnoy zhelezy
by: - -
Published: (2007-09-01)

Ad\"yuvantnaya endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
by: V F Semiglazov, et al.
Published: (2007-06-01)

Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya
by: M O Myasnikova
Published: (2007-09-01)

Odnomomentnye mastektomii i laparoskopicheskie ovariektomii v lechenii raka molochnoy zhelezy
by: R A Khvastunov, et al.
Published: (2007-09-01)

HER-2-targetnaya terapiya raka molochnoy zhelezy: monoklonal'nye antitela i ingibitory tirozinkinazy
by: I N Ognerubova
Published: (2009-06-01)

Femara (letrozol) v sovremennoy terapii raka molochnoy zhelezy
by: N I Perevodchikova
Published: (2008-06-01)

Press-release. «Sanofi» makes a contribution in improving availability of treatment in women with breast cancer in Russia in accordance with international standards
by: - -
Published: (2014-06-01)

Ways to improve the results of conservative surgery in breast cancer patients
by: I. A. Lalak
Published: (2015-03-01)

Review of the article “Choice of urine deriv ation method after r adical cystectomy in the high anesthesiological risk gr oup”
by: K. M. Figurin
Published: (2020-04-01)

Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade
by: M R Lichinitser, et al.
Published: (2009-12-01)

Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom
by: L G Zhukova, et al.
Published: (2009-09-01)

Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy?
by: V V Ptushkin
Published: (2007-03-01)

Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
by: L E Zavalishina, et al.
Published: (2009-06-01)

Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy
by: E V Artamonova
Published: (2009-12-01)

Rol' Taksotera v lechenii metastaticheskogo raka molochnoy zhelezy
by: I V Kolyadina, et al.
Published: (2009-06-01)

8 let nadezhdy: novye dannye issledovaniya ATAS
by: - -
Published: (2008-03-01)

Bevatsizumab (Avastin) v kombinatsii s taksanami v 1-y linii lecheniya HER-2-negativnogo metastaticheskogo raka molochnoy zhelezy(Rezul'taty issledovaniya AVADO)
by: L G Zhukova
Published: (2009-03-01)

Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
by: - -
Published: (2009-12-01)

The endometrium in women receiving adjuvant tamoxifen therapy after surgical treatment of breast cance
by: E V Dmitrieva, et al.
Published: (2013-12-01)